With a goal of making precision medicine the standard of care at health systems, Sema4 struck a nearly $800 million deal with CM Life Sciences to go public. The company, which offers tools that combine genomic and clinical data to glean patient care insights, will get $500 million in cash proceeds to grow its business.
People with private insurance report poorer access to care, higher costs and lower satisfaction as compared to those with public insurance plans, a new study shows. As the debate over health insurance reform continues, policymakers should consider efforts that expand Medicare and increase protections for those with private insurance.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
The concierge-like primary care startup is valued at more than $1 billion, with backers including Google Ventures.
Despite Pfizer’s (NYSE:PFE) decision to end its pilot social media recruitment initiative for a 10-state clinical trial for overactive bladder drug Detrol, the effort marks an important first step to reduce the costs of drug development. In an interview with Pharmalot, Pfizer’s head of clinical innovation, Craig Lipset, said recruitment had been “very challenging,” but […]